• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Skeletal Muscle Loss During Neoadjuvant Therapy for Esophageal Cancer: Is it an Unpreventable Event due to Tumor Progression or Manageable by Intervention?

作者信息

Watanabe Masayuki

机构信息

Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.

出版信息

Ann Surg Oncol. 2024 Nov;31(12):7661-7662. doi: 10.1245/s10434-024-15937-y. Epub 2024 Aug 3.

DOI:10.1245/s10434-024-15937-y
PMID:39097553
Abstract
摘要

相似文献

1
Skeletal Muscle Loss During Neoadjuvant Therapy for Esophageal Cancer: Is it an Unpreventable Event due to Tumor Progression or Manageable by Intervention?食管癌新辅助治疗期间的骨骼肌丢失：这是肿瘤进展导致的不可避免事件，还是可通过干预进行控制？
Ann Surg Oncol. 2024 Nov;31(12):7661-7662. doi: 10.1245/s10434-024-15937-y. Epub 2024 Aug 3.
2
Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.新辅助治疗期间骨骼肌量的丢失与食管癌预后不良相关：一项回顾性队列研究。
World J Surg Oncol. 2018 Feb 12;16(1):27. doi: 10.1186/s12957-018-1327-4.
3
ASO Author Reflections: Significance of Skeletal Muscle Loss After Neoadjuvant Chemoradiation for Esophageal Cancer.ASO作者反思：新辅助放化疗后食管癌患者骨骼肌丢失的意义
Ann Surg Oncol. 2024 Jun;31(6):3854-3855. doi: 10.1245/s10434-024-14968-9. Epub 2024 Jan 24.
4
Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.骨骼肌量与局部晚期食管癌新辅助放化疗期间毒性增加相关：SAKK 75/08 亚研究。
Radiat Oncol. 2019 Sep 11;14(1):166. doi: 10.1186/s13014-019-1372-3.
5
Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.骨骼肌减少和肌少症对新辅助放化疗局部晚期食管癌结局的影响。
Ann Surg Oncol. 2024 Jun;31(6):3819-3829. doi: 10.1245/s10434-024-14936-3. Epub 2024 Jan 20.
6
Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis.新辅助治疗期间骨骼肌减少作为食管和食管胃结合部癌症患者的预后指标：系统评价和荟萃分析。
Int J Surg. 2022 Jan;97:106206. doi: 10.1016/j.ijsu.2021.106206. Epub 2022 Jan 4.
7
Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.新辅助化疗期间骨骼肌丢失是晚期食管癌患者术后感染并发症的独立危险因素。
Oncology. 2018;95(5):281-287. doi: 10.1159/000490616. Epub 2018 Aug 27.
8
Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer.新辅助化疗期间肠内营养支持对食管癌患者骨骼肌量保存的临床效果。
Clin Nutr. 2021 Jun;40(6):4380-4385. doi: 10.1016/j.clnu.2021.01.007. Epub 2021 Jan 12.
9
Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.新辅助放化疗期间骨骼肌质量的丧失可预测食管癌手术的术后死亡率。
Ann Surg Oncol. 2015 Dec;22(13):4445-52. doi: 10.1245/s10434-015-4558-4. Epub 2015 Apr 17.
10
Usefulness of skeletal muscle measurement by computed tomography in patients with esophageal cancer: changes in skeletal muscle mass due to neoadjuvant therapy and the effect on the prognosis.利用计算机断层扫描测量骨骼肌在食管癌患者中的作用：新辅助治疗引起的骨骼肌质量变化及其对预后的影响。
Surg Today. 2023 Jun;53(6):692-701. doi: 10.1007/s00595-023-02657-1. Epub 2023 Feb 10.

本文引用的文献

1
Correction: Recent Advances in Diagnosing and Treating Post-Prostatectomy Urinary Incontinence.
Ann Surg Oncol. 2024 Nov;31(12):8472. doi: 10.1245/s10434-024-16220-w.
2
Multimodal Prehabilitation During Neoadjuvant Therapy Prior to Esophagogastric Cancer Resection: Effect on Cardiopulmonary Exercise Test Performance, Muscle Mass and Quality of Life-A Pilot Randomized Clinical Trial.术前新辅助治疗期间行多模态预康复对胃食管交界癌切除术后心肺运动试验表现、肌肉质量和生活质量的影响：一项前瞻性随机临床试验
Ann Surg Oncol. 2022 Mar;29(3):1839-1850. doi: 10.1245/s10434-021-11002-0. Epub 2021 Nov 1.
3
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.新辅助放化疗联合手术治疗食管癌的 10 年结果：随机对照 CROSS 试验。
J Clin Oncol. 2021 Jun 20;39(18):1995-2004. doi: 10.1200/JCO.20.03614. Epub 2021 Apr 23.
4
Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial.全程营养管理对食管癌同步放化疗患者的影响：一项随机对照试验。
Nutrition. 2020 Jan;69:110558. doi: 10.1016/j.nut.2019.110558. Epub 2019 Jul 23.
5
Enteral Nutrition Support Does Not Improve PNI in Radiotherapy Patients with Locally Advanced Esophageal Cancer.肠内营养支持并不能改善局部晚期食管癌放疗患者的 PNI。
Nutr Cancer. 2019;71(2):223-229. doi: 10.1080/01635581.2018.1559939. Epub 2019 Jan 20.
6
Lung Cancer Cachexia: Can Molecular Understanding Guide Clinical Management?肺癌恶病质：分子层面的认识能否指导临床管理？
Integr Cancer Ther. 2018 Sep;17(3):1000-1008. doi: 10.1177/1534735418781743. Epub 2018 Jun 13.
7
Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.肌肉减少症：在局部晚期食管癌的多模态管理中，其流行率及对手术和肿瘤学结局的影响。
Ann Surg. 2017 Nov;266(5):822-830. doi: 10.1097/SLA.0000000000002398.
8
Cachexia: a new definition.恶病质：一个新定义。
Clin Nutr. 2008 Dec;27(6):793-9. doi: 10.1016/j.clnu.2008.06.013. Epub 2008 Aug 21.